Related Experiment Video

Updated: Jul 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

A two-hit mechanism for pre-mitotic arrest of cancer cell proliferation by a polyamide-alkylator conjugate

David Alvarez1, C James Chou, Lucia Latella

  • 1Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.

Cell Cycle (Georgetown, Tex.)
|July 25, 2006
PubMed

Insights

Polyamide-chlorambucil conjugate (1R-Chl) causes cancer cell G2/M arrest by inducing DNA damage and downregulating histone H4c. This conjugate offers a novel approach to cell cycle regulation in cancer therapy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Polyamide-chlorambucil conjugate (1R-Chl) is known to arrest human cancer cell lines at the G2/M phase.
  • 1R-Chl also downregulates histone H4c gene expression, but the precise mechanism and its relation to cell cycle arrest were unclear.

Purpose of the Study:

  • To elucidate the mechanism by which 1R-Chl induces G2/M arrest.
  • To determine the role of histone H4c downregulation in the cellular response to 1R-Chl.

Main Methods:

  • Cell cycle analysis using flow cytometry.
  • Western blotting to detect protein phosphorylation (H2A.X, cdc2) and protein recruitment (Nbs1).
  • RNA interference (siRNA) to downregulate specific gene expression (H4c, H3).

Main Results:

  • 1R-Chl downregulates histone H4c expression before inducing G2/M arrest.
  • 1R-Chl causes extensive DNA damage, evidenced by H2A.X phosphorylation and Nbs1 recruitment.
  • The G2/M arrest is mediated by cdc2 phosphorylation at tyrosine 15, leading to abolished cdc2 kinase activity.
  • A control conjugate induced G2/M arrest when H3 or H4c were silenced via siRNA.

Conclusions:

  • 1R-Chl-induced G2/M arrest is a consequence of significant DNA damage, not solely H4c downregulation.
  • Histone H4c downregulation precedes the G2/M arrest, suggesting a complex interplay in the cellular response.
  • The findings provide insights into the molecular mechanisms of polyamide-chlorambucil conjugates in cancer cell cycle regulation.

More Related Videos

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...